Rantala JK - Search Results

1

Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2.

Rantala JK, Edgren H, Lehtinen L, Wolf M, Kleivi K, Vollan HK, Aaltola AR, Laasola P, Kilpinen S, Saviranta P, Iljin K, Kallioniemi O. Rantala JK, et al. Neoplasia. 2010 Nov;12(11):877-88. doi: 10.1593/neo.10548. Neoplasia. 2010. PMID: 21082043 Free PMC article.

2

Integrin trafficking regulated by Rab21 is necessary for cytokinesis.

Pellinen T, Tuomi S, Arjonen A, Wolf M, Edgren H, Meyer H, Grosse R, Kitzing T, Rantala JK, Kallioniemi O, Fässler R, Kallio M, Ivaska J. Pellinen T, et al. Among authors: rantala jk. Dev Cell. 2008 Sep;15(3):371-385. doi: 10.1016/j.devcel.2008.08.001. Dev Cell. 2008. PMID: 18804435 Free article.

3

FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

Gupta S, Iljin K, Sara H, Mpindi JP, Mirtti T, Vainio P, Rantala J, Alanen K, Nees M, Kallioniemi O. Gupta S, et al. Cancer Res. 2010 Sep 1;70(17):6735-45. doi: 10.1158/0008-5472.CAN-10-0244. Epub 2010 Aug 16. Cancer Res. 2010. PMID: 20713528

4

A cell spot microarray method for production of high density siRNA transfection microarrays.

Rantala JK, Mäkelä R, Aaltola AR, Laasola P, Mpindi JP, Nees M, Saviranta P, Kallioniemi O. Rantala JK, et al. BMC Genomics. 2011 Mar 28;12:162. doi: 10.1186/1471-2164-12-162. BMC Genomics. 2011. PMID: 21443765 Free PMC article.

5

SHARPIN is an endogenous inhibitor of β1-integrin activation.

Rantala JK, Pouwels J, Pellinen T, Veltel S, Laasola P, Mattila E, Potter CS, Duffy T, Sundberg JP, Kallioniemi O, Askari JA, Humphries MJ, Parsons M, Salmi M, Ivaska J. Rantala JK, et al. Nat Cell Biol. 2011 Sep 25;13(11):1315-24. doi: 10.1038/ncb2340. Nat Cell Biol. 2011. PMID: 21947080 Free PMC article.

6

Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion.

Björkman M, Östling P, Härmä V, Virtanen J, Mpindi JP, Rantala J, Mirtti T, Vesterinen T, Lundin M, Sankila A, Rannikko A, Kaivanto E, Kohonen P, Kallioniemi O, Nees M. Björkman M, et al. Oncogene. 2012 Jul 19;31(29):3444-56. doi: 10.1038/onc.2011.512. Epub 2011 Nov 28. Oncogene. 2012. PMID: 22120715

7

Epigenetics of prostate cancer and the prospect of identification of novel drug targets by RNAi screening of epigenetic enzymes.

Björkman M, Rantala J, Nees M, Kallioniemi O. Björkman M, et al. Epigenomics. 2010 Oct;2(5):683-9. doi: 10.2217/epi.10.48. Epigenomics. 2010. PMID: 22122051

8

A functional genetic screen reveals new regulators of β1-integrin activity.

Pellinen T, Rantala JK, Arjonen A, Mpindi JP, Kallioniemi O, Ivaska J. Pellinen T, et al. Among authors: rantala jk. J Cell Sci. 2012 Feb 1;125(Pt 3):649-61. doi: 10.1242/jcs.090704. J Cell Sci. 2012. PMID: 22389402

9

The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition.

Fredlund E, Staaf J, Rantala JK, Kallioniemi O, Borg A, Ringnér M. Fredlund E, et al. Among authors: rantala jk. Breast Cancer Res. 2012 Jul 27;14(4):R113. doi: 10.1186/bcr3236. Breast Cancer Res. 2012. PMID: 22839103 Free PMC article.

10

MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer.

Cekaite L, Rantala JK, Bruun J, Guriby M, Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI. Cekaite L, et al. Among authors: rantala jk. Neoplasia. 2012 Sep;14(9):868-79. doi: 10.1593/neo.121094. Neoplasia. 2012. PMID: 23019418 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page